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A Chloroplast Transgenic Approach to Hyper-Express and Purify Human Serum
Albumin, a Protein Highly Susceptible to Proteolytic Degradation
Abstract
Human Serum Albumin (HSA) accounts for 60% of the total protein in blood serum and it is the most
widely used intravenous protein in a number of human therapies. HSA, however, is currently extracted only
from blood because of a lack of commercially feasible recombinant expression systems. HSA is highly
susceptible to proteolytic degradation in recombinant systems and is expensive to purify. Expression of
HSA in transgenic chloroplasts using Shine-Dalgarno sequence (SD), which usually facilitates hyperexpression of transgenes, resulted only in 0.02% HSA in total protein (tp). Modification of HSA regulatory
sequences using chloroplast untranslated regions (UTRs) resulted in hyper-expression of HSA (up to
11.1% tp), compensating for excessive proteolytic degradation. This is the highest expression of a
pharmaceutical protein in transgenic plants and 500-fold greater than previous reports on HSA
expression in transgenic leaves. Electron micrographs of immunogold labelled transgenic chloroplasts
revealed HSA inclusion bodies, which provided a simple method for purification from other cellular
proteins. HSA inclusion bodies could be readily solubilized to obtain a monomeric form using appropriate
reagents. The regulatory elements used in this study should serve as a model system for enhancing
expression of foreign proteins that are highly susceptible to proteolytic degradation and provide
advantages in purification, when inclusion bodies are formed.
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Summary
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Human Serum Albumin (HSA) accounts for 60% of the total protein in blood serum and it is the
most widely used intravenous protein in a number of human therapies. HSA, however, is currently
extracted only from blood because of a lack of commercially feasible recombinant expression
systems. HSA is highly susceptible to proteolytic degradation in recombinant systems and is
expensive to purify. Expression of HSA in transgenic chloroplasts using Shine-Dalgarno sequence
(SD), which usually facilitates hyper-expression of transgenes, resulted only in 0.02% HSA in
total protein (tp). Modification of HSA regulatory sequences using chloroplast untranslated
regions (UTRs) resulted in hyper-expression of HSA (up to 11.1% tp), compensating for excessive
proteolytic degradation. This is the highest expression of a pharmaceutical protein in transgenic
plants and 500-fold greater than previous reports on HSA expression in transgenic leaves. Electron
micrographs of immunogold labelled transgenic chloroplasts revealed HSA inclusion bodies,
which provided a simple method for purification from other cellular proteins. HSA inclusion
bodies could be readily solubilized to obtain a monomeric form using appropriate reagents. The
regulatory elements used in this study should serve as a model system for enhancing expression of
foreign proteins that are highly susceptible to proteolytic degradation and provide advantages in
purification, when inclusion bodies are formed.

Keywords
chloroplast genetic engineering; biopharmaceuticals; genetically modified crops; molecular
farming; recombinant human blood proteins

Introduction
Availability of recombinant human proteins has revolutionized the use of therapeutically
valuable proteins in clinical medicine. Plants offer a suitable alternative to microbial or
animal expression of biopharmaceutical proteins because of their inexpensive production
costs and absence of human pathogens. However, there are some limitations. In particular,
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expression of human proteins in nuclear transgenic plants has been disappointingly low, e.g.
human serum albumin 0.02% of total soluble protein (tsp), human Interferon-β 0.000017%
of fresh weight, human epidermal growth factor 0.001% of tsp and erythropoietin 0.0026%
of tsp (Daniell et al., 2001d). Therefore, it is important to increase levels of expression in
order to exploit plant production of pharmacologically important proteins.
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As an alternative to nuclear expression, the chloroplast transgenic approach has been
developed as an effective tool for the expression of biopharmaceutical proteins in plants
(Daniell and Dhingra, 2002; Daniell et al., 2001a,b; DeGray et al., 2001; Guda et al., 2000;
Staub et al., 2000). After the first demonstration of a protein based polymer expression with
varied medical applications (Guda et al., 2000), transgenic chloroplasts have been shown to
express very small antimicrobial peptides without fusion proteins (DeGray et al., 2001),
assemble functional oligomers with disulphide bonds of the cholera toxin β-subunit (Daniell
et al., 2001b), and express a monoclonal antibody with coordinated expression and assembly
of heavy and light chain with proper folding and formation of disulphide bridges (Daniell et
al., 2001a), suggesting that adequate redox environment or required chaperonins are present
within chloroplasts. Expression of functional human somatotropin in transgenic tobacco
chloroplasts established that chloroplasts are capable of proper folding of human proteins
with disulphide bonds (Staub et al., 2000). The ability to express multiple genes in a single
transformation event (Daniell and Dhingra, 2002; De Cosa et al., 2001), accumulation of
exceptionally large quantities of foreign proteins (De Cosa et al., 2001), successful
engineering of tomato chromoplasts for high level transgene expression in fruits (Ruf et al.,
2001), coupled to hyper-expression of vaccine antigens (Daniell et al., 2001b), and the use
of plant derived antibiotic free selectable markers (Daniell et al., 2001c), augur well for oral
delivery of edible vaccines and biopharmaceuticals that are currently beyond the reach of
those who need them most. In addition, chloroplast genetic engineering is an
environmentally friendly approach, offering containment of transgenes and a solution to
gene silencing and position effect encountered in nuclear transgenic plants (Bogorad, 2000;
Daniell and Dhingra, 2002; Daniell et al., 2002; Daniell, 2002).
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HSA is the most widely used intravenous protein and is prescribed in multigram quantities
to replace blood volume in trauma and in various other clinical situations (Peters, 1995).
HSA is a monomeric globular prepro-protein whose mature form consists of a single
polypeptide chain of 585 amino acids (66.5 kDa with 17 disulphide bonds). The annual
world need exceeds 500 tons, representing a market value of more than $1.5 billion. To date,
albumin has been produced primarily by the fractionation of blood serum. Lack of
glycosylation facilitates production of functional HSA in prokaryotic systems. Although the
HSA gene and cDNA have been expressed in a wide variety of microbial systems, including
E. coli (Latta et al., 1987), Bacillus subtilis (Saunders et al., 1987), Saccharomyces
cerevisiae (Quirk et al., 1989), Kluyveromyces (Fleer et al., 1991) or Pichia pastoris (Ohtani
et al., 1998), no system is yet commercially feasible. Sijmons et al. (1990) made the first
reported attempt to express HSA in transgenic plants, but very low expression levels were
attained (0.02% tsp). HSA could not be detected if expressed in the cytoplasm, suggesting
that the protein is not stable in this compartment, due to high susceptibility to proteolytic
degradation. A 10-fold increase in HSA accumulation has been reported recently by nuclear
transformation of potato plants and targeting the HSA to the tuber apoplast (Farran et al.,
2002). Estimates by industry, however, suggest that the cost-effective yield for
pharmaceutical production is 0.1 mg of HSA per gram of fresh weight (Farran et al., 2002).
In addition, good recombinant systems are still not available for many human proteins that
are expensive to purify or highly susceptible to proteolytic degradation. It is known that
traditional purification of biopharmaceuticals using columns accounts for 30% of the
production cost and 70% of the set up cost (Petrides et al., 1995). Proteolytic degradation is
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another serious concern for industrial bioprocessing. The increasing production of proteins
in heterologous hosts through the use of recombinant DNA technology has brought this
problem into focus; heterologous proteins appear to be more prone to proteolysis (Enfors,
1992). Recombinant proteins are often regarded by a cell as foreign and therefore degraded
much faster than most endogenous proteins (Rozkov et al., 2000). Proteolytic stability of
recombinant proteins is a significant factor influencing the final yield.
This study attempts to develop a more efficient method of recombinant HSA production,
which may be used as a model system to enrich or purify biopharmaceutical proteins from
transgenic plants, which are highly susceptible to proteolytic degradation.

Results and discussion
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Two chloroplast transformation vectors were designed with different 5′ regulatory
sequences to direct HSA expression and maximize protein accumulation in transgenic
chloroplasts. Basic pLD vector, developed in this laboratory for chloroplast transformation,
was used (Daniell et al., 1998; Daniell et al., 2001b; De Cosa et al., 2001; Guda et al., 2000;
Kota et al., 1999). In the plasmid pLDAsdHSA (Figure 1a), the aadA gene, which confers
spectinomycin resistance, and the HSA gene are expressed as a polycistron from the plastid
Prrn promoter. The Shine-Dalgarno (SD) consensus sequence GGAGG was placed upstream
of both genes. High levels of foreign protein expression in chloroplasts (3–21% of tsp) have
been shown for different proteins using this 5′ sequence (Daniell et al., 2001b; DeGray et
al., 2001; Kota et al., 1999). In the pLDApsbAHSA vector (Figure 1a), the 204 bp tobacco
chloroplast DNA fragment containing the promoter and the psbA 5′ UTR was inserted
immediately upstream of the HSA coding sequence and downstream of the aadA gene. It is
well known that foreign genes under the control of the psbA promoter and untranslated
region are expressed at very high levels (Daniell et al., 1990). This enhancement of
translation may be due to elements in the 5′UTR (Eibl et al., 1999). Vectors were
bombarded into tobacco leaves as described previously (Daniell, 1997) and, after 5 weeks,
several primary shoots appeared from each bombarded leaf as a result of independent
transformation events. Putative transformed shoots were identified by growth on 500 μg/mL
of spectinomycin.
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Integration of the foreign gene cassettes into the chloroplast genome was confirmed by PCR
screening of primary shoots. The strategy employed lands one primer on the native
chloroplast genome adjacent to the point of integration and the second primer on the aadA
gene. This PCR product can not be obtained in nuclear transgenic plants or spontaneous
mutants, thus both possibilities could be eliminated. It was found that 90% of total shoots
obtained were true chloroplast transformants. Confirmed transformants were subjected to a
second round of spectinomycin selection to achieve homoplasmy. They were rooted in the
presence of spectinomycin and then transferred to pots for further characterization. Southern
blot analysis was performed to select homoplasmic T0 lines and confirm stable maintenance
of integrated transgenes in the T1 generation (Figure 1b–d). The flanking region probe (P1)
identified a 7.45 kb fragment in the untransformed control plant, as expected (Figure 1c). In
the chloroplast transgenic lines, only transformed genome copies are observed as evidenced
by the 10.5 and 10.7 kb hybridizing fragments for pLDAsdHSA and pLDApsbAHSA
transgenic lines, respectively. To confirm that the 10.5 and 10.7 kb fragments contained the
HSA gene, the same blot was reprobed with the HSA P2 probe. As expected, hybridization
was detected only in the chloroplast transgenic lines (Figure 1d). Absence of other
hybridizing fragments eliminates nuclear and chloroplast integration events in the same
transgenic line.
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HSA quantities in transgenic tobacco chloroplasts were determined by ELISA. More than a
360-fold difference in HSA accumulation was observed between plants transformed with the
two different vectors (Figure 3a): 0.02% vs. 7.2% tp in pLDAsdHSA and pLDApsbAHSA
transgenic lines, respectively. Chloroplast constructs with the SD sequence have been
demonstrated to direct CTB expression very efficiently (up to 4% of tsp; Daniell et al.,
2001b). Similar constructs, but inserted in other areas of the plastid genome, have also been
successful (3–21% tsp; DeGray et al., 2001; Kota et al., 1999), demonstrating that high
protein expression levels can be achieved by using this construct in an operon with a SD
sequence. Thus, low levels of HSA expression in the pLDAsdHSA transgenic plants could
not be due to the effect of regulatory signals in the construct. Differences in the amounts of
HSA could be due to post-transcriptional, translational or post-translational effects. To study
differences in HSA expression, transcript abundance was examined by Northern blots,
which were performed using the 3′psbA region as the probe (Figure 2). The 5′psbA/HSA
monocistron transcript is much more abundant than the aadA/SD/HSA dicistron, but such
differences do not show a linear correlation with the 360-fold difference in HSA
accumulation between both transgenic lines. Such a lack of correlation between transcript
abundance and protein accumulation has been reported from several laboratories when the
psbA 5′UTR is used (Mayfield et al., 1995; Staub and Maliga, 1993, 1994), suggesting an
important role of the psbA 5′UTR in enhancement of translation. Eibl et al. (1999) also
showed that deletion of the terminal sequences of the psbA 5′UTR decreased the ability of
the UTR to enhance translation. Thus, efficient translation in the pLDApsbAHSA transgenic
line might be an important factor in establishing high levels of HSA accumulation.
There are several studies demonstrating that psbA 5′UTR confers light-dependent
translation not only to the psbA gene (Zerges, 2000) but also to other heterologous proteins
(Eibl et al., 1999; Staub and Maliga, 1993, 1994). Expression of HSA under the psbA
5′UTR control is therefore expected to be light dependent. Changes in HSA accumulation
after different periods of illumination were monitored by ELISA (Figure 3b). HSA quantity
was observed to be maximum up to 50 h of continuous illumination (11.1% of tp) in mature
leaves and a 2–4-fold decrease was observed after the 8 h dark period. Such differences in
HSA accumulation were so pronounced that it was detected by staining gels with Coomassie
Brilliant Blue (Figure 3c). Staub and Maliga (1993, 1994) and Eibl et al. (1999) showed that
although translation is arrested in the dark, the 5′psbA/uidA mRNA turnover was very low.
This observation was confirmed for HSA by Northern blot analysis, which showed no major
differences between light and dark amount of 5′psbA/HSA transcripts (Figure 2, lanes 3, 4).
Therefore, differences in HSA accumulation between dark and light could not be due to
differences in the rate of transcription or transcript stability, but due to the arrest of
translation in the dark and the turnover of HSA in the chloroplast.
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Proteins from transformed plants were separated to study the pattern of HSA accumulation
within transgenic chloroplasts. Western blots confirmed differences in HSA quantities
among transgenic lines (Figure 3d). In pLDApsbAHSA transgenic lines, HSA is partially
solubilized with the standard buffer used for total protein extraction. This observation
suggests formation of HSA aggregates inside transgenic chloroplasts in the pLDApsbAHSA
transformants. Electron microscopy and immunogold labelling therefore were performed in
transformed and untransformed plants to further investigate this. As expected, electron
micrographs of leaf tissues showed formation of large aggregates or inclusion bodies within
transgenic chloroplasts of pLDApsbAHSA mature transformed plants (Figure 4b–d). It is
interesting to note that chloroplasts containing inclusion bodies increased in size to
accommodate large accumulation of HSA (compare Figures 4a,d). However, the phenotype
of these plants appeared normal (Figure 5). The amount of HSA in pLDAsdHSA transgenic
chloroplasts was so low that it was not possible to detect immunogold labelling above the
background. No significant changes in chloroplast size were observed in these plants.
Plant Biotechnol J. Author manuscript; available in PMC 2012 October 26.
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Inclusion bodies have been often observed in the cytosol of prokaryotes and eukaryotes
when heterologous proteins are overexpressed. The occurrence of this feature in the
chloroplast was first reported by Ketchner et al. (1995). It is widely known that protein
aggregation into inclusion bodies mostly involves intermolecular associations of partially
folded intermediates (Mitraki and King, 1989). High protein concentrations usually lead to
conditions that frequently exceed the normal solubility limit. Even the most abundant
protein in photosynthetic cells, RuBisCO, forms inclusion bodies in some cases. Many
autotrophic bacteria and all cyanobacteria package much of the RuBisCO into inclusion
bodies actively involved in the fixation of CO2, known as carboxysomes (Shively and
English, 1991). Our hypothesis, based on the process of formation of inclusion bodies, is
that in contrast to pLDAs-dHSA transgenic lines, HSA synthesized under the psbA 5′UTR
forms large aggregates mainly due to the high local concentration of the protein.
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Formation of inclusion bodies is one of the strategies for reducing the proteolysis of unstable
recombinant proteins (Enfors, 1992). The majority of recombinant proteins studied have
been shown to be highly resistant to proteolysis inside inclusion bodies. Although there is
protection from proteases within inclusion bodies, some proteolysis can also take place
directly on the aggregated protein (Carrio et al., 1999). HSA also appears to be susceptible
to some proteolytic degradation within transgenic chloroplasts. However, the net balance
between synthesis and degradation is highly favourable, especially after several hours of
continuous illumination.
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Properly folded HSA can be recovered from inclusion bodies after denaturation for complete
solubilization and in vitro refolding. Proper refolding of HSA from inclusion bodies is a
routine procedure that has been previously demonstrated in several studies with E. coli
(Latta et al. (1987) and Saccharomyces cerevisiae (Dodsworth et al., 1996; Quirk et al.,
1989). In these cases, human and recombinant refolded HSA were compared and it was
shown that the two proteins were structurally equivalent, demonstrating that HSA may be
recovered from inclusion bodies and properly folded. Following the guidelines from these
protocols, HSA was extracted from transgenic chloroplasts. Figure 6a shows a silver stained
SDS-PAGE gel in which HSA inclusion bodies could be separated from the soluble fraction
(lane 3), where most of the cellular proteins are found. After solubilization of inclusion
bodies and subsequent refolding, HSA could be completely converted into monomeric forms
(Figure 6a, lane 5; Figure 6b, lane 5). Our estimations of HSA yields at the end of the
protocol are about 20% of the initial quantities in leaves, although the reported protocol has
been performed at the laboratory scale and may be further optimized for industrial
production. Expression of HSA in transgenic plants has been estimated to be cost effective
with levels of expression as low as 0.1 mg HSA/g fresh weight (Farran et al., 2002). The
recoveries after solubilizing the inclusion bodies and refolding the HSA are about 0.25 mg
HSA/g fresh weight (excluding soluble HSA in transgenic chloroplasts), which exceeds cost
effective estimations of pharmaceutical industries.
One of the primary goals of this study was to develop a more efficient expression system for
human serum albumin, an important human therapeutic protein that is highly susceptible to
degradation. Expression of HSA in mature plants under the translational control of SD
sequence resulted in very low levels of HSA accumulation, probably due to excessive
proteolytic degradation and poor rates of translation. However, when expressed under the
control of psbA promoter and 5′UTR, up to a 500-fold increase in HSA accumulation was
observed in mature plants compared to other regulatory sequences tested. HSA was
observed to form large inclusion bodies, resulting even in a noticeable increase in the size of
transgenic chloroplasts and presumably offering protection to HSA from proteolytic
degradation. Inclusion bodies facilitated purification of HSA from other cellular proteins.
The HSA molecule has a chemical and structural function rather than an enzymatic activity,
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therefore complex studies are necessary to fully demonstrate the functionality of the
molecule (see Dodsworth et al., 1996; Ohtani et al., 1998; Petersen et al., 2000; Tarelli et al.,
1998; Watanabe et al., 2001a,b). Such functional studies using in vitro refolded HSA are in
progress.

Experimental procedures
Chloroplast expression vectors
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pLDAsdHSA was constructed by inserting the HSA 1.8 kb EcoRI/NotI fragment into the
multiple cloning site of the pLD vector (Daniell et al., 1998; Daniell et al., 2001b; De Cosa
et al., 2001; Guda et al., 2000; Kota et al., 1999). This fragment contains the mature HSA
coding sequence preceded by a Shine-Dalgarno (GGAGG) and it has an ATG as the
initiation codon. These sequences were introduced by using the primer: 5′GGAGGCAACCATGGATGCACACAAGAGTGAAGG-3′. For the pLDApsbAHSA
vector, the 204 bp sequence including the promoter and the psbA 5′UTR, was amplified by
PCR using tobacco DNA as template. The following primers were used: 5′CCGTCGACGTAGAGAAGTCCGTATT-3′ and 5′GCCCATGGTAAAATCTTGGTTTATTTA-3′. The fusion with the HSA gene was made at
the NcoI site placed at the 3′ end of the psbA 5′UTR and then inserted into the pLD vector
as a EcoRI/NotI fragment. Before proceeding with the bombardment, vectors were tested by
Western blot analysis in E. coli.
Bombardment and regeneration
Sterile tobacco (cv. Petit Havana) leaves were bombarded using the Bio-Rad PDS-1000/He
biolistic device as described previously (Daniell, 1997). Bombarded leaves were subjected
to two rounds of selection on the RMOP medium containing 500 μg/mL of spectinomycin to
regenerate transformants (Daniell, 1997). After regeneration, plants were rooted on 500 μg/
mL of spectinomycin (Daniell et al., 2001b) and transferred to pots in growth chambers.
Photoperiod was 16 h light and 8 h dark.
PCR and Southern blot analysis
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PCR was used to analyse integration of different cassettes in the transformed plants as
described (Daniell et al., 2001b,c; De Cosa et al., 2001; Kota et al., 1999). For Southern blot
analysis, total DNA was extracted from leaves of transformed and untransformed plants
(Qiagen Dneasy Kit). Total DNA (5 μg) was digested with BamHI, electrophoresed on 0.7%
agarose gels and transferred to nylon membranes (Duralon-UV Stratagene). The template
for probing flanking sequences was a 0.81 kb BglII/BamHI fragment and for HSA a 0.75 kb
NcoI fragment. The probes were labelled with 32P-dCTP using the oligolabelling procedure
(Ready To Go, Amersham). Probes were hybridized to the membranes following the
QUICK-HYB protocol (Duralon-UV, Stratagene).
Northern blot analysis
Total RNA was extracted from leaves of transformed and untransformed plants (Rneasy
Plant Kit, Qiagen). RNA 2.5 μg was electrophoresed on 1.2% agarose/formaldehyde gels
and then transferred to nylon membranes (Stratagene). A 0.21 kb XbaI/PstI fragment of the
3′psbA gene was used as probe and labelled with 32P-dCTP using the oligolabelling
procedure (Amersham).
HSA quantification
The ELISA Human Albumin Quantification Kit (Bethyl Laboratories) was used.
Transformed and untransformed leaves (100 mg) from potted plants grown under a 16 h
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photoperiod were ground in liquid nitrogen, resuspended in 700 μL of 50 mM NaOH and
analysed following the manufacturer’s protocol. Transgenic leaf extracts were diluted to fit
in the linear range of the provided HSA standard. Absorbance was read at 450 nm. The DC
protein assay (Bio-Rad) was used to determine total solubilized protein.
SDS-PAGE and immunoblot analysis
Transformed and untransformed leaves (100 mg) were ground in liquid nitrogen and
resuspended in 200 μL of protein extraction buffer (200 mM Tris-HCl pH 8.0, 100 mM
NaCl, 400 mM Sucrose, 14 mM βME, 0.05% Tween20, 0.1% SDS, 10 mM EDTA, 2 mM
PMSF). Leaf extracts were boiled in sample buffer (Bio-Rad) and electrophoresed in a 10%
polyacrylamide gel. Separated proteins were stained with Coomassie Brilliant Blue G-250 or
transferred to a nitrocellulose membrane for immunoblotting. The primary antibody (rabbit
anti-HSA, Nordic Immunology) was used at 1 : 10 000 dilution, and the secondary antibody
(alkaline phosphatase conjugated mouse antirabbit, Sigma or goat antirabbit HRP
conjugated, Southern Biotechnology) at 1 : 15 000. Alkaline phosphatase colour
development reagents, BCIP/NBT, in AP Color Development Buffer (Bio-Rad) or the ECL
kit (Amersham) were used for detection.
Solubilization of inclusion bodies
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Soluble proteins were removed with a first extraction in 0.2 M NaCl, 25 mM Tris-HCl pH
7.4, 2 mM PMSF and 0.1% Triton X-100. After centrifugation for 60 min at 20 000 g, the
pellet was solubilized for 16 h at 4 °C in 6 M Gu-HCl, 0.1 M βME and 0.25 mM Tris-HCl
pH 7.4. After centrifugation for 60 min at 20 000 g, the supernatant was then slowly diluted
100-fold in 100 mM NaCl, 50 mM Tris-HCl pH 8.5 and 1 mM EDTA for 24 h at 4 °C.
Fractions were electrophoresed in a SDS-PAGE 10% gel and silver stained with Bio-Rad
reagents and protocol.
Transmission electron microscopy and immunogold labelling
Seedlings and mature leaves from untransformed and transgenic plants were analysed.
Fixation and immunogold labelled electron microscopy were performed as described by
Vrekleij and Leunissen (1989). Sections were first blocked, incubated for 1 h with a goat
antihuman albumin polyclonal antibody (Nordic Immunology; dilution range from 1 : 1000
to 1 : 10 000) and then incubated for 2 h with a rabbit antig-oat IgG secondary antibody
conjugate to 10 nM gold diluted 1 : 40 in blocking solution. Sections were examined in a
Zeiss EM 10 transmission electron microscope at 60 kV.
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Figure 1.

Integration of transgene cassettes into the chloroplast genome and study of homoplasmy. (a)
Regions for homologous recombination are underlined in the native chloroplast genome.
HSA is driven in all cassettes by the Prrn promoter upstream of the aadA gene for
spectinomycin resistance with additional promoters and control elements as described in the
text. Arrows within boxes show the direction of transcription. Numbers to the right indicate
the predicted hybridizing fragments when total DNA digested with BamHI is probed with
probe P1. (b) The 0.81 kb fragment (P1) flanking the cassette and 0.75 kb fragment
containing HSA coding region (P2) were used as probes for the Southern blot analysis. (c, d)
Southern blot analysis. 1: untransformed DNA; DNA from plants transformed with: 2,3:
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pLDAsdHSA; 4,5: pLDApsbAHSA. Plants for the first (T0) and second (T1) generation
were analysed. 2,4: T0 generation. 3,5: T1 generation. Blots were probed with P1 (c) and P2
(d). AadA: aminoglycoside 3′-adenylyl transferase; kb: kilobases; P: promoter; Prrn:
16SrRNA promoter; SD: Shine-Dalgarno.

NIH-PA Author Manuscript
NIH-PA Author Manuscript
Plant Biotechnol J. Author manuscript; available in PMC 2012 October 26.

Millán et al.

Page 12

NIH-PA Author Manuscript
NIH-PA Author Manuscript
NIH-PA Author Manuscript

Figure 2.

Transcription patterns of transgenic plants. A Northern blot analysis was performed with
total RNA extracted from leaves of potted plants. The 3′ of the psbA gene was used as
probe. 1: untransformed plant; 2: transformed with pLDAsdHSA; 3: transformed with
pLDApsbAHSA after illumination or 4: in the dark. Ethidium bromide-stained rRNA was
used to assess loading. Identified transcripts are indicated to the right. A scheme of
transcription patterns expected for the different cassettes integrated into the chloroplast
genome is shown at the bottom of the figure. Horizontal arrows above genes show
anticipated transcripts. Arrows within boxes show the orientation of genes within the
chloroplast genome. Read through transcripts are not shown in this figure. rRNA: ribosomal
RNA.
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Figure 3.
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Analysis of HSA accumulation in transgenic chloroplasts. (a) ELISA of HSA accumulation
in leaves of potted plants at different stages of development. Samples were collected from
untransformed plants or transformed with pLDAsdHSA or pLDApsbAHSA. Expression
levels are indicated as a percentage of total protein. (b) Study after different hours of
illumination. Samples of leaves were collected from potted plants transformed with
pLDApsbAHSA after the 8-h dark period or at indicated hours in the light. (c) Coomassie
stained gel to study HSA accumulation in tobacco leaves of potted plants. Total protein
extracts were loaded in the gel. 1: 500 ng pure HSA; 2: molecular weight marker; 3:
untransformed plant; transformed with 4: pLDAsdHSA; 5: pLDApsbAHSA after 8 h of
illumination; 6: pLDApsbAHSA after 8 h of darkness. Between 40 and 50 μg of plant
protein were loaded per well. The positions of HSA and RuBisCO large subunit (LSU) are
marked. (d) Colorimetric immunoblot detection of tobacco protein extracts from mature
leaves in potted plants. Total protein extracts were loaded in the gel. 1: 40 ng pure HSA; 2:
molecular weight marker; 3,5: untransformed plant extract; 4: pLDAsdHSA plant extract; 6:
pLDApsbAHSA plant extract. Between 40 and 50 μg of plant protein were loaded per well.
kDa: kiloDalton; LSU: RuBisCO large subunit.
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Figure 4.

Study of HSA accumulation into inclusion bodies. (a–d) Electron micrographs of
immunogold labelled tissues from untransformed (a) and transformed mature leaves with the
chloroplast vector pLDApsbAHSA (b–d). Note presence of inclusion bodies (b–d) marked
with an arrow in (d). Scale bars indicate μm. Magnifications are a × 10 000; b × 5000; c
× 6300; d × 12 500.
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Figure 5.

Plant T1 phenotypes. 1,2: untransformed plants; 3: plant transformed with pLDAsdHSA; 4:
plant transformed with pLDApsbAHSA.
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Figure 6.
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HSA extraction from inclusion bodies. (a) Silver stained SDS-PAGE gel showing 1: 500 ng
pure HSA; 2: molecular weight marker; soluble fraction obtained after centrifugation of
pLDApsbAHSA transformed plant extract (lane 3) or untransformed plant extract (lane 4);
5: HSA after solubilization from the pellet; 6: proteins from untransformed plant, which
followed the same process as the proteins of lane 5. Amounts of protein loaded per well
were 10 μg in lanes 3 and 4, 550 ng in lane 5 and 450 ng in lane 6. (b) Chemiluminiscent
immunoblot detection of protein extracts. 1: 40 ng pure HSA; 2: HSA from a plant
transformed with pLDApsbAHSA during the solubilization process, showing mono, di and
trimeric forms; 3: proteins from an untransformed plant that followed the same process as
the proteins for lane 2; 4: same HSA from lane 2 but in a more advanced stage of
solubilization; 5: completely monomerized HSA after the end of the solubilization treatment
(the sample of this lane corresponds with lane 5 in (a)).
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